BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18183483)

  • 1. An unusual member of the Cdk family: Cdk5.
    Dhariwala FA; Rajadhyaksha MS
    Cell Mol Neurobiol; 2008 May; 28(3):351-69. PubMed ID: 18183483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
    Chen J; Wang ZF
    Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk5: multitasking between physiological and pathological conditions.
    Lopes JP; Agostinho P
    Prog Neurobiol; 2011 Jun; 94(1):49-63. PubMed ID: 21473899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
    Schmid G; Strosznajder JB; Wesierska-Gadek J
    Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Xenopus laevis homologue to the neuronal cyclin-dependent kinase (cdk5) is expressed in embryos by gastrulation.
    Gervasi C; Szaro BG
    Brain Res Mol Brain Res; 1995 Nov; 33(2):192-200. PubMed ID: 8750877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5.
    Arif A
    Biochem Pharmacol; 2012 Oct; 84(8):985-93. PubMed ID: 22795893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5--a neuronal killer?
    Guo Q
    Sci Aging Knowledge Environ; 2003 Dec; 2003(50):pe36. PubMed ID: 14681576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk5 activity in the brain - multiple paths of regulation.
    Shah K; Lahiri DK
    J Cell Sci; 2014 Jun; 127(Pt 11):2391-400. PubMed ID: 24879856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocols for Characterization of Cdk5 Kinase Activity.
    Terse A; Amin N; Hall B; Bhaskar M; B K B; Utreras E; Pareek TK; Pant H; Kulkarni AB
    Curr Protoc; 2021 Oct; 1(10):e276. PubMed ID: 34679246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special Issue on "Cdk5 and Brain Disorders": Prologue.
    Kanungo J
    Brain Disord Ther; 2012; Suppl 1():. PubMed ID: 28066692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
    Kesavapany S; Zheng YL; Amin N; Pant HC
    Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease.
    Allnutt AB; Waters AK; Kesari S; Yenugonda VM
    ACS Chem Neurosci; 2020 May; 11(9):1218-1230. PubMed ID: 32286796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.
    Shah K; Rossie S
    Mol Neurobiol; 2018 Apr; 55(4):3426-3438. PubMed ID: 28502042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk5 regulates multiple cellular events in neural development, function and disease.
    Kawauchi T
    Dev Growth Differ; 2014 Jun; 56(5):335-48. PubMed ID: 24844647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells.
    Strocchi P; Pession A; Dozza B
    J Cell Biochem; 2003 Mar; 88(4):758-65. PubMed ID: 12577309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.
    Tian Z; Feng B; Wang XQ; Tian J
    Front Mol Neurosci; 2022; 15():1030639. PubMed ID: 36438186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.
    Hisanaga S; Endo R
    J Neurochem; 2010 Dec; 115(6):1309-21. PubMed ID: 21044075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinases in brain development and disease.
    Su SC; Tsai LH
    Annu Rev Cell Dev Biol; 2011; 27():465-91. PubMed ID: 21740229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.